Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Mononuclear Blood Cells by the Iron Chelators Deferoxamine, Deferiprone, and Bleomycin
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Replication of human immunodeficiency virus type 1 (HIV-1) can be influenced by iron. Hence, decreasing the availability of iron may inhibit HIV-1 replication. Deferoxamine and deferiprone, both forming catalytically inactive iron-chelator complexes, and bleomycin, by use of which iron catalyzes oxidative nucleic acid destruction, were investigated. Expression of p24 antigen in human monocyte-derived macrophages and peripheral blood lymphocytes (PBL) was reduced by all 3 iron chelators. In PBL, p24 reduction was mirrored by a decrease in proliferation after incubation with deferoxamine or deferiprone, suggesting that viral inhibition is closely linked to a decrease in cellular proliferation. In contrast, clinically relevant bleomycin concentrations reduced p24 levels by approximately 50% without affecting proliferation. When deferoxamine and the nucleoside analogue dideoxyinosine were used in combination, they acted synergistically in inhibiting HIV-1 replication. These observations suggest that iron chelators with different mechanisms of action could be of additional benefit in antiretroviral combination therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178 · cited 4×
“The combined-drug effect was evaluated by the median-effect principle and the isobologram method [26].”
MethodResultInfluentialZack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
The Design of Orally Active Iron Chelators
HIDER, R. C., & ZHOU, T. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.017 · Cited by 64
Cited by
Viral infection and iron metabolism
Drakesmith, H., & Prentice, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1930 · Cited by 469
TER KUILE, F. O., PARISE, M. E., VERHOEFF, F. H., UDHAYAKUMAR, V., NEWMAN, R. D., VAN EIJK, A. M., ROGERSON, S. J., & STEKETEE, R. W. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.41 · Cited by 364
The role of autophagy in viral infections
Chen, T., Tu, S., Ding, L., Jin, M., Chen, H., & Zhou, H. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00899-2 · Cited by 221
Host-Pathogen Interactions: The Role of Iron1,
Doherty, C. P. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.5.1341 · Cited by 186
“In vitro studies have suggested that viral replication is inhibited after iron chelation (36).”
BackgroundIron and infection: competition between host and microbes for a precious element
MARX, J. (2002) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2002.0001 · Cited by 129
Self-citation
Metadata
- Authors
- Georgiou, N. A., van der Bruggen, T., Oudshoorn, M., Nottet, H. S. L. M., Marx, J. J. M., & van Asbeck, B. S.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-02
- Volume
- 181
- Issue
- 2
- Pages
- 484-490
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2152187456
- Cited by
- 105
- References
- 3
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Mononuclear Blood Cells by the Iron Chelators Deferoxamine, Deferiprone, and Bleomycin. https://app.cochat.ai/papers/10.1086/315223
- The paper
- Georgiou, N. A., van der Bruggen, T., Oudshoorn, M., Nottet, H. S. L. M., Marx, J. J. M., & van Asbeck, B. S. (2000). Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Mononuclear Blood Cells by the Iron Chelators Deferoxamine, Deferiprone, and Bleomycin. The Journal of Infectious Diseases. https://doi.org/10.1086/315223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.